A 68-year-old woman with noncardioembolic stroke received endoscopic hemostasis for UGIB yesterday. She is stable now. When considering antiplatelet r...

Question

A 68-year-old woman with noncardioembolic stroke received endoscopic hemostasis for UGIB yesterday. She is stable now. When considering antiplatelet resumption, which is generally appropriate?

Accepted Answer

Resume single antiplatelet once hemostasis is secured and risk balanced

Answer

Delay all antiplatelets indefinitely

Answer

Use DAPT indefinitely

Answer

Start anticoagulation instead

Answer

Avoid PPI after resumption

us-abim MCQ (SBA): UGIB-Antiplatelet Resumption

A 68-year-old woman with noncardioembolic stroke received endoscopic hemostasis for UGIB yesterday. She is stable now. When considering antiplatelet resumption, which is generally appropriate?